| 摘要 |
PROBLEM TO BE SOLVED: To provide pharmaceutical formulations for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example, damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis.SOLUTION: The invention also provides controlled or sustained release preparation of a Class B corticosteroid that includes lactic acid-glycolic acid copolymer microparticles containing the Class B corticosteroid, where the Class B corticosteroid account for 22% to 28% of the lactic acid-glycolic acid copolymer microparticle matrix.SELECTED DRAWING: None |
